No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Raymond James Maintains NeoGenomics(NEO.US) With Hold Rating
Needham Maintains NeoGenomics(NEO.US) With Buy Rating, Maintains Target Price $19
Needham Reiterates Buy on NeoGenomics, Maintains $19 Price Target
NeoGenomics Down Over 15%, On Track for Largest Percent Decrease Since December 2023 -- Data Talk
NeoGenomics Shares Are Trading Lower. The Company Announced Its CEO Will Retire Effective the First of April.
Craig-Hallum Maintains NeoGenomics(NEO.US) With Buy Rating